Symbol="VOR"
AssetType="Common Stock"
Name="Vor Biopharma Inc"
Description="Vor Biopharma, Inc., an early stage cell therapy company, develops hematopoietic stem cell (eHSC) therapies designed for cancer patients. The company is headquartered in Cambridge, Massachusetts."
CIK="1817229"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="215 FIRST STREET, SUITE 430, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="195187000"
EBITDA="-108191000"
PERatio="None"
PEGRatio="None"
BookValue="3.032"
DividendPerShare="0"
DividendYield="0"
EPS="-2.03"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.293"
ReturnOnEquityTTM="-0.559"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.03"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="14.22"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.579"
EVToRevenue="-"
EVToEBITDA="-1.827"
Beta="-0.85"
num_52WeekHigh="7.57"
num_52WeekLow="2.5"
num_50DayMovingAverage="3.274"
num_200DayMovingAverage="4.733"
SharesOutstanding="67539000"
DividendDate="None"
ExDividendDate="None"
symbol="VOR"
open="2.79"
high="2.92"
low="2.73"
price="2.76"
volume="67363.00"
latest_trading_day="2023-08-24"
previous_close="2.80"
change="-0.04"
change_percent="-1.4286%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="169993"
Change_recent_avg="-0.04"
Delta_recent_avg="0.3"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="-1.15"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="502"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0103.jpeg"
image_negative_thumbnail_id_2="147"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0029.jpeg"
image_neutral_thumbnail_id_1="538"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_neutral_thumbnail_id_2="562"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_positive_thumbnail_id_1="950"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0112.jpeg"
image_positive_thumbnail_id_2="963"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0125.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
